Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 28.
doi: 10.1111/bph.17370. Online ahead of print.

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

Laith Alexander  1   2 , Dasha Anderson  3 , Luke Baxter  1   2 , Matthew Claydon  3 , James Rucker  1   2 , Emma S J Robinson  3
Affiliations
Free article
Review

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

Laith Alexander et al. Br J Pharmacol. .
Free article

Abstract

Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid-acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood. For example, key questions such as whether antidepressant and psychedelic effects involve related or independent mechanisms are unresolved. Preclinical studies in relevant animal models are key to understanding the pharmacology of psychedelics and translating these findings to explain efficacy and safety in patients. Understanding the mechanisms of action associated with the behavioural effects of psychedelic drugs can also support the identification of novel drug targets and more effective treatments. Here we review the behavioural approaches currently used to quantify the psychedelic and antidepressant effects of psychedelic drugs. We discuss conceptual and methodological issues, the importance of using clinically relevant doses and the need to consider possible sex differences in preclinical psychedelic studies.

Keywords: antidepressant; behaviour; hallucinogenic; neuropsychology; translation.

PubMed Disclaimer

References

REFERENCES

    1. Adams, L. M., & Geyer, M. A. (1982). LSD‐induced alterations of locomotor patterns and exploration in rats. Psychopharmacology, 77(2), 179–185. https://doi.org/10.1007/bf00431945
    1. Aghajanian, G. K., & Marek, G. J. (2000). Serotonin model of schizophrenia: Emerging role of glutamate mechanisms. Brain Research Reviews, 31(2–3), 302–312. https://doi.org/10.1016/s0165-0173(99)00046-6
    1. Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Abbracchio, M. P., Abraham, G., Agoulnik, A., Alexander, W., Al‐Hosaini, K., Bäck, M., Baker, J. G., Barnes, N. M., … Ye, R. D. (2023). The Concise Guide to PHARMACOLOGY 2023/24: G protein‐coupled receptors. British Journal of Pharmacology, 180, S23–S144. https://doi.org/10.1111/bph.16177
    1. Al‐Harbi, K. S. (2012). Treatment‐resistant depression: Therapeutic trends, challenges, and future directions. Patient Preference and Adherence, 6, 369–388. https://doi.org/10.2147/PPA.S29716
    1. Almaula, N., Ebersole, B. J., Ballesteros, J. A., Weinstein, H., & Sealforn, S. C. (1996). Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5‐hydroxytryptamine2A and 5‐hydroxytryptamine2C receptors: Direct and indirect effects on ligand affinity mediated by the same locus. Molecular Pharmacology, 50(1), 34–42. https://pubmed.ncbi.nlm.nih.gov/8700116/

LinkOut - more resources